pCW57-MCS1-2A-MCS2 Citations (17)
Originally described in: Pan-Cancer Analyses Reveal Genomic Features of FOXM1 Overexpression in Cancer.Barger CJ, Branick C, Chee L, Karpf AR Cancers (Basel). 2019 Feb 21;11(2). pii: cancers11020251. doi: 10.3390/cancers11020251. PubMed Journal
Articles Citing pCW57-MCS1-2A-MCS2
| Articles |
|---|
| An inducible form of Nrf2 confers enhanced protection against acute oxidative stresses in RPE cells. Vu KT, Hulleman JD. Exp Eye Res. 2017 Nov;164:31-36. doi: 10.1016/j.exer.2017.08.001. Epub 2017 Aug 4. PubMed |
| The Vaccinia Virus B12 Pseudokinase Represses Viral Replication via Interaction with the Cellular Kinase VRK1 and Activation of the Antiviral Effector BAF. Rico AB, Linville AC, Olson AT, Wang Z, Wiebe MS. J Virol. 2021 Jan 13;95(3):e02114-20. doi: 10.1128/JVI.02114-20. Print 2021 Jan 13. PubMed |
| A global phylogenetic analysis of Japanese tonsil-derived Epstein-Barr virus strains using viral whole-genome cloning and long-read sequencing. Yajima M, Kakuta R, Saito Y, Kitaya S, Toyoda A, Ikuta K, Yasuda J, Ohta N, Kanda T. J Gen Virol. 2021 Mar;102(3). doi: 10.1099/jgv.0.001549. Epub 2021 Jan 12. PubMed |
| Characterization of SALL2 Gene Isoforms and Targets Across Cell Types Reveals Highly Conserved Networks. Farkas C, Quiroz A, Alvarez C, Hermosilla V, Aylwin CF, Lomniczi A, Castro AF, Hepp MI, Pincheira R. Front Genet. 2021 Feb 22;12:613808. doi: 10.3389/fgene.2021.613808. eCollection 2021. PubMed |
| WWTR1(TAZ)-CAMTA1 reprograms endothelial cells to drive epithelioid hemangioendothelioma. Driskill JH, Zheng Y, Wu BK, Wang L, Cai J, Rakheja D, Dellinger M, Pan D. Genes Dev. 2021 Apr 1;35(7-8):495-511. doi: 10.1101/gad.348221.120. Epub 2021 Mar 25. PubMed |
| Novel TREM2 splicing isoform that lacks the V-set immunoglobulin domain is abundant in the human brain. Kiianitsa K, Kurtz I, Beeman N, Matsushita M, Chien WM, Raskind WH, Korvatska O. J Leukoc Biol. 2021 Jun 1. doi: 10.1002/JLB.2HI0720-463RR. PubMed |
| Downregulation of CRX, a Group 3-specific oncogenic transcription factor, inhibits TGF-beta/activin signaling in medulloblastoma cells. Masurkar SA, Deogharkar A, Bharambe HS, Shirsat NV. Biochem Biophys Res Commun. 2021 Sep 3;568:76-82. doi: 10.1016/j.bbrc.2021.06.064. Epub 2021 Jun 27. PubMed |
| EVI1 activates tumor-promoting transcriptional enhancers in pancreatic cancer. Kim HR, Yim J, Yoo HB, Lee SE, Oh S, Jung S, Hwang CI, Shin DM, Kim T, Yoo KH, Kim YS, Lee HW, Roe JS. NAR Cancer. 2021 Jun 17;3(2):zcab023. doi: 10.1093/narcan/zcab023. eCollection 2021 Jun. PubMed |
| Unbiased proteomic mapping of the LINE-1 promoter using CRISPR Cas9. Briggs EM, Mita P, Sun X, Ha S, Vasilyev N, Leopold ZR, Nudler E, Boeke JD, Logan SK. Mob DNA. 2021 Aug 23;12(1):21. doi: 10.1186/s13100-021-00249-9. PubMed |
| Viral immune evasins impact antigen presentation by allele-specific trapping of MHC I at the peptide-loading complex. Sethumadhavan S, Barth M, Spaapen RM, Schmidt C, Trowitzsch S, Tampe R. Sci Rep. 2022 Jan 27;12(1):1516. doi: 10.1038/s41598-022-05000-9. PubMed |
| Dysregulation of Cellular VRK1, BAF, and Innate Immune Signaling by the Vaccinia Virus B12 Pseudokinase. Linville AC, Rico AB, Teague H, Binsted LE, Smith GL, Albarnaz JD, Wiebe MS. J Virol. 2022 Jun 8;96(11):e0039822. doi: 10.1128/jvi.00398-22. Epub 2022 May 11. PubMed |
| Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stress. Liu X, Viswanadhapalli S, Kumar S, Lee TK, Moore A, Ma S, Chen L, Hsieh M, Li M, Sareddy GR, Parra K, Blatt EB, Reese TC, Zhao Y, Chang A, Yan H, Xu Z, Pratap UP, Liu Z, Roggero CM, Tan Z, Weintraub ST, Peng Y, Tekmal RR, Arteaga CL, Lippincott-Schwartz J, Vadlamudi RK, Ahn JM, Raj GV. Nat Cancer. 2022 Jul;3(7):866-884. doi: 10.1038/s43018-022-00389-8. Epub 2022 Jun 2. PubMed |
Programmable RNA sensing for cell monitoring and manipulation.
Qian Y, Li J, Zhao S, Matthews EA, Adoff M, Zhong W, An X, Yeo M, Park C, Yang X, Wang BS, Southwell DG, Huang ZJ.
Nature. 2022 Oct;610(7933):713-721. doi: 10.1038/s41586-022-05280-1. Epub 2022 Oct 5.
PubMed
Associated Plasmids |
| Cullin-5 deficiency orchestrates the tumor microenvironment to promote mammary tumor development through CREB1-CCL2 signaling. Chen S, Shao F, Zeng J, Guo S, Wang L, Sun H, Lei JH, Lyu X, Gao S, Chen Q, Miao K, Xu X, Deng CX. Sci Adv. 2023 Jan 20;9(3):eabq1395. doi: 10.1126/sciadv.abq1395. Epub 2023 Jan 20. PubMed |
| The Zn(2+) transporter ZIP7 enhances endoplasmic-reticulum-associated protein degradation and prevents neurodegeneration in Drosophila. Guo X, Mutch M, Torres AY, Nano M, Rauth N, Harwood J, McDonald D, Chen Z, Montell C, Dai W, Montell DJ. Dev Cell. 2024 Jul 8;59(13):1655-1667.e6. doi: 10.1016/j.devcel.2024.04.003. Epub 2024 Apr 25. PubMed |
| PRMT1 promotes epigenetic reprogramming associated with acquired chemoresistance in pancreatic cancer. Nguyen CDK, Colon-Emeric BA, Murakami S, Shujath MNY, Yi C. Cell Rep. 2024 May 28;43(5):114176. doi: 10.1016/j.celrep.2024.114176. Epub 2024 Apr 30. PubMed |
CRISPR-Cas13d screens identify KILR, a breast cancer risk-associated lncRNA that regulates DNA replication and repair.
Wang L, Bitar M, Lu X, Jacquelin S, Nair S, Sivakumaran H, Hillman KM, Kaufmann S, Ziegman R, Casciello F, Gowda H, Rosenbluh J, Edwards SL, French JD.
Mol Cancer. 2024 May 15;23(1):101. doi: 10.1186/s12943-024-02021-y.
PubMed
Associated Plasmids |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.